Skip to main content
Equibles

UBS Group AG

Position in DARE — Dare Bioscience, Inc.

CIK 1610520 ZURICH, V8
Back to DARE Full portfolio

Position in DARE

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$14,369
-$64,550 QoQ
Shares Held
6,810
-84.3% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 27 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DARE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,672,124 across 561 Biotechnology names. DARE ranks #438 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in DARE

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,369 6,810
2026-03-31 $78,919 43,363
2025-12-31 $40,365 20,915
2025-09-30 $47,503 22,621
2025-06-30 $35,868 15,008
2025-03-31 $63,842 22,091
2024-12-31 $101,065 32,393
2024-09-30 $2,867 885
2024-06-30 $33,268 99,016
2024-03-31 $244 500
2023-12-31 $2,656 8,600
2023-09-30 $230 500
2023-06-30 $454 500
2023-03-31 $519 500
2022-12-31 $23,172 27,920
2022-09-30 $56,490 56,492
2022-06-30 $614 500
2022-03-31 $7,843 5,265
2021-12-31 $30,258 15,130
2021-09-30 $834 500
2021-06-30 $20,717 10,962
2021-03-31 $844 500
2020-12-31 $669 500
2020-09-30 $499 500
2020-06-30 $494 500
2020-03-31 $32,725 38,502